Comments
Strides Shasun has got approval from the US health regulator for pain reliever drug ibuprofen.
The product will be marketed by Strides Pharma Inc in the US market under its OTC brand Nuprin, Strides Shasun said in a BSE filing today.
Quoting IRi data, the drug firm said that the US market for ibuprofen tablets USP 200 mg is approximately $520 million.
Strides Shasun stock was trading higher by 4.71 per cent at Rs 947.95 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.